Insulin and Beta Cell Targeting

Type2 diabetes mellitus is a chronic disease without cure. When beta-cell function progressively declines mostly, then blood glucose level rises only. However, recent studies have demonstrated remission of Type2 diabetes raising the possibility that the declining beta-cell function in Type2 diabetes may be arrested or even reversed, following bariatric surgery, intensive insulin therapy or very low-calorie diet. To focus on to early beta-cell preservation and people sickness remissions future treatment ways ought to be revised.

  • Effects of the incretions on β-cell mass
  • Targeting β-cell mass in type 2 diabetes
  • Targeting the pancreatic β-cell to treat diabetes
  • The incretion effect and its mediators
  • B-cell science
  • Implications for treatment

Related Conference of Insulin and Beta Cell Targeting

September 09-10, 2024

33rd International Diabetes and Healthcare Conference

Paris, France
September 09-10, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
September 25-26, 2024

5th World Summit on Diabetes Expo

Rome, Italy
October 14-15, 2024

3rd International Summit on Hormonal Disorders

Madrid, Spain
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Insulin and Beta Cell Targeting Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in